Immune checkpoint inhibitors and myocarditis in advanced non-small cell lung cancer: a nationwide cohort study

Immune checkpoint inhibitors and myocarditis in advanced non-small cell lung cancer: a nationwide cohort study

Abstract Objective Evidence suggests immune checkpoint inhibitor (ICI) can increase the risk of myocarditis. We investigated it in a large national cohort in China. Methods Patients with stage IIIB-IV non-small cell lung cancer (NSCLC) using data from China's National Anti-Tumor Drug Surveillan...

Full description

Saved in:
Bibliographic Details
Main Authors: Fu-Xiao Li, Jia-Xin Cai, Ji-Bin Li, Kong-Jia Luo, Shi-Yu Wang, Wei-Hua Meng, Feng Sha, Zhi-Rong Yang, Allan Hackshaw, Jin-Ling Tang
Format: Article
Language:English
Published: BMC 2025-03-01
Series:Cardio-Oncology
Subjects:
Non-small cell lung cancer
Immune checkpoint inhibitor
Myocarditis
Cohort study
Real-world evidence
Cardiotoxicity
Online Access:https://doi.org/10.1186/s40959-025-00325-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s40959-025-00325-6

Similar Items